Better COVID-19 Stock: Merck or Pfizer?

It's not surprising that COVID-19 has attracted many of the biggest drugmakers on the planet. Pfizer (NYSE: PFE) launched the best-selling vaccine Comirnaty with the help of its partner, BioNTech. Merck (NYSE: MRK) is likely to soon have the first COVID-19 pill on the market.

Pfizer has delivered greater stock gains than Merck since the beginning of the pandemic. But which is the better COVID-19 stock going forward? Here's how the two pharma stocks stack up against each other.

Image source: Getty Images.

Continue reading

Source Fool.com